MedTrace Logo

Microparticles Circulating Plasma Concentration in Atrial Fibrillation After Percutaneous Occluding of the Left Atrium

NCT03361202 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-12-04

No results posted yet for this study

Summary

The aim of the study is to compare levels of differnts types of microparticles circulating before and after percutaneous occluding of the left atrium by patients with atrial fibrillation and patients control.

Hypothesis is that prothesis implantation will decrease levels of microparticles circulating in blood circulation because of occluding of the left atrium .

Conditions

Interventions

OTHER

blood sampling

* atrial fibrillation group:before Percutaneous Occluding of the Left Atrium, at hospital discharge and at J45 follow up * control group:before coronary angiography and at hospital discharge.

Sponsors & Collaborators

  • Société Française de Cardiologie

    collaborator OTHER

  • Institut Mutualiste Montsouris

    lead OTHER

Principal Investigators

  • Nicolas AMABILE · Institut Mutualiste Montsouris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-01-31
Completion
2018-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03361202 on ClinicalTrials.gov